Acute Telogen Effluvium: A Sequela of COVID-19 Infection

May 2022 in “ GLOBAL JOURNAL FOR RESEARCH ANALYSIS ”

Tejas kant, Upma Narain, Arun Kant

acute Telogen Effluvium TE COVID-19 SARS-CoV-2 hair loss Telogen Effluvium

Studysummary This study found that 74.6% of COVID-19 patients in Prayagraj experienced telogen effluvium hair loss, predominantly affecting females.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer

View this study on worldwidejournals.com →

Discuss this study in the Community →

Research cited in this study

11 / 11 results

research Telogen Effluvium: A Sequela of COVID-19

58 citations , November 2020 in “International Journal of Dermatology”

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

research Telogen Effluvium Related to Post Severe SARS-CoV-2 Infection: Clinical Aspects and Our Management Experience

35 citations , November 2020 in “Dermatologic Therapy”

This case series reports telogen effluvium in three patients following severe Sars-Cov-2 infection and suggests a potential association that merits further investigation.

research Acute Telogen Effluvium Associated with SARS-CoV-2 Infection

24 citations , August 2020 in “AJGP”

A woman's sudden hair loss was linked to her previous COVID-19 infection.

research A Review of the Dermatological Manifestations of Coronavirus Disease 2019 (COVID-19)

26 citations , August 2020 in “Dermatology Research and Practice”

This review discusses the various skin manifestations and problems related to COVID-19 and associated treatments, but it reports no new clinical findings.

research Evaluation of the Effects of COVID-19 Pandemic on Hair Diseases Through a Web-Based Questionnaire

39 citations , June 2020 in “Dermatologic Therapy”

In this study, individuals reported a decrease in dermatologist visits for hair and scalp conditions like telogen effluvium and alopecia areata during COVID-19 quarantine, despite increased occurrences.

research Postfebrile Telogen Effluvium: Hair Fall After Rickettsia Conorii Infection

5 citations , January 2019 in “Giornale italiano di dermatologia e venereologia”

Hair loss can happen after a fever caused by Rickettsia conorii infection.

research Dengue Virus Infects Primary Human Hair Follicle Dermal Papilla Cells

14 citations , August 2018 in “Frontiers in Cellular and Infection Microbiology”

This study found that dengue virus infection caused inflammation and cell death in human hair-follicle dermal papilla cells, which may contribute to increased hair shedding observed during the epidemic in Taiwan.

research Telogen Effluvium as First Clinical Presentation of Dengue

3 citations , February 2017 in “Italian journal of dermatology and venereology”

Hair loss might be the first sign of dengue fever.

research Telogen Effluvium: A Review

70 citations , January 2015 in “Journal of Clinical and Diagnostic Research”

This review discusses the various triggers and diagnostic challenges in determining the cause of telogen effluvium-related hair loss, without providing new clinical results.

research The Biology of Hair Follicles

1113 citations , August 1999 in “The New England Journal of Medicine”

This article discusses the biologic and psychosocial significance of hair, the current limitations in hair growth drugs, and anticipates future therapies based on advancing hair follicle research.

research Interleukin-1β Is Differentially Expressed by Human Dermal Papilla Cells in Response to PKC Activation and Is a Potent Inhibitor of Human Hair Follicle Growth in Organ Culture

38 citations , March 1997 in “Journal of interferon & cytokine research”

This study suggests that IL-1β produced by dermal papilla cells, regulated by protein kinase C, may inhibit human hair follicle growth through paracrine signaling.